VIPpharma ApS: Financial statements 2022
CVR: 38744763
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
VIPpharma ApS (CVR 38744763) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,357,487 and a net result of DKK 633,504 compared with DKK 428,487 the year before. That is an increase of 13.5% compared with the year before. Equity in the 2022 report amounted to DKK 2,003,597. The solvency ratio was 68.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,357,487
- Profit/Loss
- DKK 633,504
- Equity
- DKK 2,003,597
- Total Assets
- DKK 2,912,980
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.4 mio. | 634 t. | 2 mio. | 2 |
| 2021 | - | 2.1 mio. | 428 t. | 2.4 mio. | 2 |
| 2020 | - | 2.2 mio. | 716 t. | 3.7 mio. | 2 |
| 2019 | - | 1.1 mio. | -173 t. | 3.1 mio. | 2 |
| 2018 | - | 1.5 mio. | 228 t. | 3.4 mio. | - |
Official annual report
Keep an eye on VIPpharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
VIPpharma ApS has published its annual report for 2021. Gross profit came to DKK 2,076,341, and the net result was DKK 428,487.
About VIPpharma ApS
VIPpharma ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Public relations og kommunikation. The management consists of Vibeke Wærens. The company is owned by VIPinvest ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 2,432,365 and a net result of DKK 674,851 compared with DKK 1,191,483 the year before. Equity in the 2025 report amounted to DKK 1,263,395.